← Back to Search

Resistance exercise plus cool down for Type 1 Diabetes

N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 0 minutes to 45 minutes (during exercise)
Awards & highlights

Study Summary

This trial will study the effects of adding a short aerobic cool down at the end of a fasted resistance exercise session on post-exercise blood glucose levels in people with type 1 diabetes.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 0 minutes to 45 minutes (during exercise)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from 0 minutes to 45 minutes (during exercise) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
percent time spent in hyperglycemia
Secondary outcome measures
capillary glucose
frequency of hyperglycemia
frequency of hypoglycemia
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment2 Interventions
All participants will undergo two separate testing sessions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance exercise only
2022
N/A
~20
Resistance exercise plus cool down
2022
N/A
~20

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
894 Previous Clinical Trials
386,975 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are engaged in the research?

"Affirmative. Clinicaltrials.gov illustrates the current recruitment status of this clinical trial, which was initially posted on March 1st 2022 and edited most recently on March 31st 2022; enrolling 16 participants across a single site."

Answered by AI

Is it possible to become involved in this medical trial?

"In order to qualify for this trial, potential participants should have hyperglycemia and be between the ages of 18-55. The clinical team is aiming to enroll a total of 16 people in their study."

Answered by AI

Does this clinical investigation admit participants who are elderly?

"In accordance with the eligibility requirements, potential participants must be between 18 and 55 years of age."

Answered by AI

Are recruiting efforts ongoing for this clinical trial?

"According to the information accessible on clinicaltrials.gov, this trial is presently recruiting participants. The initial posting was made on March 1st 2022 and most recently modified on March 31st 2022."

Answered by AI
~5 spots leftby May 2025